Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Por um escritor misterioso
Descrição
Frontiers Dupilumab efficacy and safety in patients with
Biomedicines, Free Full-Text
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension
Biomedicines, Free Full-Text
Dupilumab efficacy in children with uncontrolled type 2 asthma
Dupilumab and tezepelumab in severe refractory asthma: new
Time effect of dupilumab to treat severe uncontrolled asthma in
Dupilumab May Improve Lung Function in Children Age 6-11 with
Dupixent Reduces Asthma Exacerbations in Younger Children
Discoveries in Medicine - Study Approves Dupilumab Option for
Dupilumab in the management of moderate-to-severe asthma: the data
Efficacy of dupilumab in asthma.
de
por adulto (o preço varia de acordo com o tamanho do grupo)
